Search ARN News Centre
Lifestyle from Tuesday, April 1st, 2025
-
European Commission approves Pfizer's RSV vaccine
The European Commission approved Pfizer's PFE.N respiratory syncytial virus vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease, the company said on Tuesday.
